Earnings Feed
Start Free
Home/Filings/3/0001104659-21-085270
3//SEC Filing

DELUCCIA ROBERT J 3

Accession 0001104659-21-085270

CIK 0001736243other
View on SEC.govCompany Profile

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 6:22 PM ET

Size

18.1 KB

Accession

0001104659-21-085270

Insider Transaction Report

Form 3
Period: 2021-06-24
Acurx Pharmaceuticals, Inc.ACXP
DELUCCIA ROBERT J
Director10% Owner
Holdings

  • Common Stock

    1,026,427

  • Warrants for Common Stock

    Exercise: $2.00From: 2018-03-20Exp: 2028-03-20→ Common Stock (6,250 underlying)

  • Common Stock

    (indirect: By Spouse)
    3,847

  • Warrants for Common Stock

    Exercise: $3.00From: 2018-10-23Exp: 2028-10-23→ Common Stock (8,334 underlying)

  • Warrants for Common Stock

    Exercise: $4.00From: 2019-03-29Exp: 2029-03-29→ Common Stock (3,125 underlying)

  • Warrants for Common Stock

    Exercise: $4.00From: 2019-08-08Exp: 2029-08-08→ Common Stock (3,125 underlying)

  • Warrants for Common Stock

    Exercise: $4.00From: 2019-10-18Exp: 2029-10-18→ Common Stock (3,125 underlying)
Footnotes (1)
  • [F1]Reflects the conversion of membership interests to common stock pursuant to the corporate conversion of Acurx Pharmaceuticals, Inc.

Documents

2 files

Issuer

Acurx Pharmaceuticals, Inc.

CIK 0001736243

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001127423

Filing Metadata

Form type
3
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 6:22 PM ET
Size
18.1 KB
View on SEC.gov